Introduction
The regulation of pharmaceuticals is one of the most sensitive areas of law, balancing public health with the rights of manufacturers, distributors, and consumers. Turkish Drug Law establishes the rules for the authorization, production, marketing, and supervision of medicines in Türkiye. It reflects both local needs and international standards, ensuring that drugs are safe, effective, and of high quality.
This article examines the legal framework of Turkish Drug Law, the role of regulatory bodies, the process of licensing and market access, restrictions on promotion, compliance obligations, and enforcement practices. For pharmaceutical companies and healthcare professionals, understanding these rules is critical to operating legally and ethically in Türkiye.
Legal Framework of Turkish Drug Law
1. Constitutional and General Principles
- The Constitution of Türkiye guarantees the right to health and empowers the state to regulate the healthcare system, including drugs.
- Pharmaceutical law is anchored in public health protection, with the state acting as both regulator and enforcer.
2. Pharmaceutical and Medical Preparations Law (Law No. 1262, 1928)
- The fundamental statute governing pharmaceuticals in Türkiye.
- Covers licensing, production, import, and distribution of drugs.
- Authorizes the Ministry of Health to issue secondary legislation.
3. Decree Law No. 663 (2011)
- Reorganized the Ministry of Health and established the Turkish Medicines and Medical Devices Authority (TITCK).
- TITCK is the primary body overseeing drug regulation.
4. Regulations and Guidelines
- Regulation on Licensing of Human Medicinal Products (2005, updated regularly).
- Regulation on Promotional Activities of Human Medicinal Products (2013).
- Good Manufacturing Practices (GMP) Guidelines.
- Pharmacovigilance Regulations (monitoring adverse drug reactions).
Regulatory Authority
Turkish Medicines and Medical Devices Authority (TITCK)
- An autonomous agency under the Ministry of Health.
- Responsibilities include:
- Granting marketing authorization (drug licensing).
- Monitoring manufacturing standards.
- Approving clinical trials.
- Regulating pharmaceutical advertising and promotion.
- Conducting inspections and imposing sanctions.
Licensing and Market Authorization
1. Marketing Authorization
- All human medicinal products require prior authorization from TITCK.
- Applicants must submit a dossier including safety, efficacy, and quality data (in line with EU CTD format).
- Authorization is product-specific and must be renewed every 5 years.
2. Clinical Trials
- Regulated by TITCK in accordance with Good Clinical Practice (GCP).
- Ethical approval from local ethics committees is mandatory.
3. Manufacturing and Importation
- Manufacturers must hold GMP certificates.
- Imported drugs require both authorization and local representation.
Pricing and Reimbursement
- Drug prices are regulated under the Reference Pricing System, based on the lowest prices in selected EU countries.
- The Social Security Institution (SGK) manages reimbursement, ensuring wide access to essential medicines.
Promotion and Advertising
- Direct-to-consumer advertising of prescription drugs is strictly prohibited.
- Promotion is limited to healthcare professionals (doctors, pharmacists, dentists).
- Over-the-counter (OTC) drugs may be advertised, but subject to strict rules on accuracy and public health.
- Influencer or covert advertising on social media is banned.
- Companies must appoint medical sales representatives trained and certified under TITCK rules.
Compliance and Monitoring
- Pharmacovigilance (Drug Safety Monitoring):
- Companies must appoint a qualified person responsible for pharmacovigilance.
- Adverse events must be reported to TITCK.
- Inspections:
- TITCK conducts regular inspections of manufacturers, distributors, and pharmacies.
- Record-keeping:
- Companies must maintain detailed records of promotional expenses, clinical trials, and adverse event reports.
Enforcement and Sanctions
- Administrative Fines: For violations of promotional restrictions, licensing obligations, or safety rules.
- Suspension or Revocation of Licenses: For repeated or serious breaches.
- Product Recall: If safety issues arise, TITCK may order recalls.
- Criminal Liability: Fraudulent practices, counterfeit medicines, and illegal drug distribution may lead to prosecution.
International Alignment
- EU Harmonization: Turkish Drug Law closely follows EU pharmaceutical directives, aligning procedures with the European Medicines Agency (EMA).
- WHO Guidelines: Safety and quality standards are influenced by WHO recommendations.
- Mutual Recognition: Türkiye participates in international cooperation to recognize GMP and pharmacovigilance standards.
Compliance Tips for Pharmaceutical Companies
- Secure all necessary licenses before production or marketing.
- Prepare complete and accurate dossiers for authorization.
- Maintain strong pharmacovigilance systems to monitor safety.
- Train medical representatives in compliance with promotional restrictions.
- Ensure transparency in pricing and reimbursement practices.
- Cooperate fully with TITCK inspections and record requests.
Conclusion
Turkish Drug Law is a comprehensive system that regulates every stage of the pharmaceutical lifecycle—from research and licensing to pricing, promotion, and monitoring. Its goal is to safeguard public health while ensuring fair competition and access to essential medicines.
For pharmaceutical companies, compliance with Turkish Drug Law is not only a legal obligation but also a cornerstone of ethical business practice. By adhering to the principles of transparency, safety, and accountability, stakeholders can contribute to a stronger healthcare system in Türkiye.
Yanıt yok